Healthcare Services

Cannabis Use Disorder Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cannabis Use Disorder Market In 2026 And What Value Is Projected For 2030?

The cannabis use disorder market has experienced substantial growth in recent years. It is projected to expand from $1.65 billion in 2025 to $1.78 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.5%. Historically, this growth can be ascribed to a number of factors including the increasing prevalence of cannabis consumption, enhanced awareness of substance use disorders, the expansion of rehabilitation infrastructure, greater recognition of mental health disorders, and the availability of behavioral therapy frameworks.

The cannabis use disorder market size is anticipated to experience robust expansion over the forthcoming years. It is forecast to reach $2.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. The projected growth is attributable to the increasing acceptance of digital mental health solutions, rising investments in addiction research, the expansion of telehealth-based treatment models, a growing focus on outcome-based care, and the increasing integration of pharmacotherapy and behavioral therapy. Significant trends within the forecast period include the increasing adoption of integrated behavioral and pharmacological treatments, a rising focus on personalized addiction therapy programs, the growing use of digital therapeutics and remote monitoring, the expansion of multidisciplinary treatment approaches, and an enhanced emphasis on early diagnosis and intervention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21126&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cannabis Use Disorder Market?

Enhanced recognition and identification of cannabis addiction are anticipated to fuel the expansion of the cannabis use disorder market in the future. This heightened awareness and diagnostic process for cannabis addiction entails informing the general public, medical practitioners, and affected persons regarding the indicators, manifestations, and hazards associated with cannabis use disorder (CUD). The uptick in awareness and diagnosis of cannabis addiction stems from multiple factors, including greater cannabis legalization and accessibility, alongside increasing scientific and medical acknowledgment of the condition. Treatment for cannabis use disorder presents an organized method for handling withdrawal effects, diminishing urges, and dealing with foundational psychological elements; this directly aids in diagnosing cannabis addiction by supplying clinical proof of dependency tendencies, emphasizing the seriousness of the condition, and directing the suitable intervention level according to the unique requirements of each individual. As an illustration, in November 2024, data from The Office for Health Improvement and Disparities, a UK-based government agency, showed that the proportion of new individuals seeking help for cannabis-related problems stayed relatively consistent this year, increasing modestly by 0.5 percentage points from 20.9% to 21.4%. Concurrently, the count of new patients presenting with benzodiazepine-related concerns rose from 3,620 in 2022–2023 to 3,872 this year. Consequently, the expanding awareness and identification of cannabis addiction are propelling the expansion of the cannabis use disorder market.

What Are The Key Segments Of The Cannabis Use Disorder Market?

The cannabis use disorder market covered in this report is segmented –

1) By Treatment: Pharmacotherapy, Behavioral Therapies

2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual

3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers

Subsegments:

1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Anxiolytics (Non-Benzodiazepine), Antipsychotics

2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy

What Key Trends Are Influencing The Development Of The Cannabis Use Disorder Market?

Major companies in the cannabis use disorder (CUD) market are concentrating on developing advanced solutions, including digital therapeutics and technology-enabled behavioral intervention platforms, to help individuals reduce or cease problematic cannabis use through structured counseling, personalized care pathways, and ongoing support. Digital therapeutics within CUD treatment refer to clinically validated, technology-driven programs that deliver behavioral therapies, track progress, and offer remote access to licensed clinicians, thereby improving adherence and long-term recovery outcomes. For instance, in April 2024, Pelago, a US-based virtual clinic specializing in substance use management, introduced a cannabis use disorder (CUD) treatment program aimed at addressing the increasing number of individuals affected by the condition, estimated at nearly 18 million adults in the U.S. Pelago’s program provides education on cannabis use and delivers evidence-based therapies such as cognitive behavioral therapy and motivational enhancement therapy, additionally extending support to adolescents aged 15-17 years through abstinence-focused treatment goals.

Who Are The Leading Companies Operating In The Cannabis Use Disorder Market?

Major companies operating in the cannabis use disorder market are Lyra Health Inc., Pyramid Healthcare Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam’s Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral Healthcare, GreeneStone

Read the full cannabis use disorder market report here:

https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report

What Are The Leading Geographic Regions In The Cannabis Use Disorder Market?

North America was the largest region in the cannabis use disorder market in 2025. The regions covered in the cannabis use disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cannabis Use Disorder Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21126&type=smp

Browse Through More Reports Similar to the Global Cannabis Use Disorder Market 2026, By The Business Research Company

Cannabis Cultivation Global Market Report

https://www.thebusinessresearchcompany.com/report/cannabis-cultivation-global-market-report

Recreational Cannabis Global Market Report

https://www.thebusinessresearchcompany.com/report/recreational-cannabis-global-market-report

Cannabis Vaporizers Global Market Report

https://www.thebusinessresearchcompany.com/report/cannabis-vaporizers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795